Welcome to our dedicated page for Zepp Health Corporation American depositary shares, each representing sixteen news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health Corporation American depositary shares, each representing sixteen stock.
Zepp Health Corporation (NYSE: ZEPP) is a leading global provider of smart wearables and health technology solutions that enable users to maximize their health, fitness, and wellness. Established in 2013 as Huami Corp., the company rebranded to Zepp Health in February 2021 to emphasize its health-centered approach. Zepp Health is renowned for its innovative brands such as Amazfit, Zepp Clarity, and Zepp Aura, which together form a comprehensive ecosystem empowering users to achieve their wellness goals.
Central to Zepp Health's offerings is the proprietary Zepp Digital Health Management Platform, which integrates advanced technologies including Zepp OS, AI chips, biometric sensors, and sophisticated data algorithms. This platform provides 24/7 actionable insights and guidance, supporting users in their everyday health and fitness journeys. To date, Zepp Health has shipped over 200 million units, with its products accessible in more than 90 countries worldwide.
Zepp Health's product portfolio is diverse, featuring smartwatches, fitness bands, and innovative devices like the Amazfit Helio Ring and Amazfit Bip 5 Unity. The company's products are designed to offer a perfect blend of style and cutting-edge technology, appealing to both professional athletes and everyday fitness enthusiasts. Notably, the Amazfit brand has garnered numerous design accolades, including the iF Design Award and the Red Dot Design Award.
Recent achievements highlight Zepp Health's commitment to excellence and community. The company has been actively involved in significant partnerships, such as sponsoring the NN Rotterdam Marathon and the Escape from Alcatraz Triathlon. Through these partnerships, Zepp Health not only promotes its high-performance wearables but also supports athletic communities worldwide.
Financially, Zepp Health reported revenues of US$39.8 million for the first quarter of 2024, with a gross margin of 36.8%. Despite a challenging market, the company's self-branded products have shown robust performance, contributing significantly to its revenue. Looking forward, Zepp Health continues to expand its product offerings and invest in strategic marketing initiatives, ensuring sustained growth and innovation.
Zepp Health's commitment to advancing health technology is further exemplified by its partnership with LiveX AI to enhance customer experiences on the Amazfit website. This collaboration utilizes AI to provide personalized and efficient customer support, setting a new standard in the industry.
For more information about Zepp Health Corporation and its innovative health technology solutions, visit www.zepp.com.
Zepp Health (NYSE: ZEPP) has announced its participation in CES Pepcom and ShowStoppers media events to showcase its latest smart wearables and health technology innovations. The company will present several new products including:
The Amazfit Active 2 Smartwatch Series featuring Zepp Coach™, Zepp Flow™ voice assistant, and 160+ sports modes; the Amazfit V1TAL Prototype, a device with advanced nutritional tracking and high-definition video capture capabilities; and the Zepp Clarity Pixie hearing aids.
Additional innovations include a revamped Zepp App with enhanced features like Zepp Coach™, Zepp Aura, and Food Log, plus new health solutions for women powered by Wild.AI integration. The showcases will take place at Caesars Palace (January 6th) and Bellagio (January 7th).
Zepp Health (NYSE: ZEPP) has announced the launch of its new Amazfit Active 2 smartwatch at CES 2025. The device features a 1.32-inch AMOLED display with 2,000 nits brightness and comes in two versions: a premium model at $129.99 with leather strap and sapphire glass, and a standard version at $99.99 with silicone strap.
The watch incorporates advanced technology including the BioTracker™ 6.0 PPG biosensor, upgraded heart rate and sleep monitoring algorithms, and new sensors for altitude and movement tracking. It offers a 10-day battery life and includes features like Zepp Flow™ for voice control and Zepp Pay for contactless payments in Europe.
The device supports over 160 sports modes, offline maps with turn-by-turn navigation, and includes Zepp Coach™ for personalized training. Pre-orders are available in the US, with global release scheduled for February 2025.
Zepp Health (NYSE: ZEPP) has launched a 'Try Before You Buy' program for OTC hearing aids at CES 2025, addressing low adoption rates among adults with hearing loss. The initiative allows customers to test three models—Clarity Omni, Clarity One, and Clarity Pixie—in their homes before purchase.
The company introduced the Zepp Clarity Pixie, a next-generation hearing aid priced at $1,499, featuring a nearly invisible design, titanium alloy shell, IPX7 water resistance, and 17-hour battery life. The device includes Clarity Boost, Smart Phone Call support, and Find Device functionality, manageable through the Zepp Clarity App with eight customizable programs.
The program aims to tackle the low adoption rate of hearing aids, as only 15-30% of adults with mild-to-moderate hearing loss currently use them. All Zepp Clarity devices are FDA-Exempt Class II medical devices, targeting adults 18 and older, and come with lifetime customer support and certified audiologist access.
Zepp Health reported Q3 2024 financial results with revenues of US$42.5 million, representing a 48.9% decrease year-over-year. The company achieved a 40.6% gross margin, its highest quarterly margin, despite reporting a net loss of US$13.3 million. Amazfit branded sales showed a 10% quarter-over-quarter increase, marking the highest sequential growth in 2024. The company's T-Rex3 smartwatch launch received positive market feedback, while total units shipped decreased to 0.7 million from 2.8 million in Q3 2023. For Q4 2024, Zepp expects revenues between US$55-70 million, representing 29-65% growth for self-branded products compared to Q3.
Zepp Health (NYSE: ZEPP) has scheduled its third quarter 2024 financial results announcement for November 18, 2024, after market close. The company will host a conference call at 8:30 p.m. Eastern Time on the same day. The earnings call will be accessible via phone and webcast, with dial-in numbers provided for US, International, Mainland China, and Hong Kong participants. A replay of the conference call will be available until November 25, 2024.
Zepp Health has launched the enhanced Zepp App 9, designed to provide a more personalized health and wellness experience for Amazfit users. The update features a streamlined interface with color-coded statistics, enhanced smart analytics, and real-time data analysis. Key additions include a daily personalized exertion score, heart health dashboard, and Zepp Aura Premium Service for advanced sleep insights. The app offers mini-apps, watch faces, and third-party integrations with platforms like Strava and adidas Running. Data protection is ensured through AWS storage and GDPR compliance.
Zepp Health (NYSE: ZEPP), a global leader in smart wearables and health technology, has regained compliance with the New York Stock Exchange's (NYSE) continued listing criterion of a minimum share price. The company received a letter from the NYSE on October 2, 2024, confirming its compliance with Section 802.01C of the NYSE Listed Company Manual.
This development follows a previous notification from the NYSE on April 30, 2024, which informed Zepp Health that it had fallen below compliance standards due to its American depositary shares' average closing price being less than $1.00 for a consecutive 30 trading-day period. With this new confirmation, Zepp Health is no longer considered below the NYSE Minimum Price Continued Listing Criterion.
Amazfit, a smart wearable brand by Zepp Health (NYSE: ZEPP), has announced HYROX world champions Meg Jacoby and Hunter McIntyre as new brand ambassadors. This follows Amazfit's recent appointment as the Official Wearable Partner & Timekeeper of HYROX, the World Series of Fitness Racing. Jacoby, who made history by completing a HYROX race in under one hour, uses the Amazfit Cheetah Pro smartwatch. McIntyre, a three-time HYROX world champion, relies on the Amazfit T-Rex series.
Amazfit's smartwatches offer advanced features including industry-leading GPS, AI-driven training programs, and the Readiness feature for recovery insights. The partnership aims to expand Amazfit's presence in the endurance sector and drive product innovation through collaboration with elite athletes.
Zepp Health (NYSE: ZEPP) has announced a change in its American Depositary Shares (ADS) ratio from 1:4 to 1:16, effective around September 16, 2024. This change will have the same effect as a one-for-four reverse ADS split. ADS holders will need to exchange every four existing ADSs for one new ADS. The company's underlying Class A ordinary shares will not be affected, and no new shares will be issued or cancelled. Zepp Health will continue trading on the NYSE under the ticker 'ZEPP'. While the ADS trading price is expected to increase proportionately, the company cannot guarantee that it will be equal to or greater than four times the previous price.
Amazfit, a brand under Zepp Health (NYSE: ZEPP), unveiled the Amazfit T-Rex 3 smartwatch at IFA Berlin. This new model combines military-grade durability with advanced features for everyday adventurers. Key highlights include:
- 16% larger and 100% brighter AMOLED display
- Up to 27 days battery life with typical usage
- Over 170 workout modes
- Enhanced privacy protection measures
- Zepp OS 4 with integrated AI and GPT-4o technology
- Zepp Pay for contactless payments in 31 European countries
The T-Rex 3 is designed for both extreme outdoor conditions and indoor workouts, featuring advanced map and workout data visibility. Pricing starts from $279.99 USD or €299.90 Euro, with availability through official Amazfit channels and retail partners.